Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BioMed Central, 2006-
    • Subject Terms:
    • Abstract:
      Background: Insomnia seriously affects people's normal lives and work. However, effective treatment strategies are scarce. The purpose of this study is to explore the efficacy and safety of Jiao-tai-wan (JTW) for ameliorating insomnia symptoms caused by disharmony of the heart and kidney.
      Design: This is a randomized, double-blind, placebo-controlled pilot clinical trial. A total of 124 participants suffering from insomnia symptoms will be randomly assigned to the JTW or placebo group in an equal ratio. The participants will be asked to take JTW or placebo granules twice a day for 1 week. All data will be gathered at baseline and at the end of the drug intervention. The primary outcome measures will be the mean change in the Pittsburgh Sleep Quality Index (PSQI) from baseline to the end of the drug intervention. Secondary outcome measures will include the altered sleep parameters in polysomnography, 1 H-magnetic resonance spectroscopy ( 1 H-MRS) evaluation, the Disharmony of Heart and Kidney Scoring System score, and blood tests, including the levels of serum adenosine and melatonin. A laboratory test will be taken before and after treatment to assess the safety of JTW.
      Discussion: The outcomes of this study will confirm the efficacy of JTW for the treatment of insomnia symptoms and will also be used to monitor the safety of JTW.
      Trial Registration: Chinese Clinical Trial Registry, ChiCTR1800019239. Registered on 1st November 2018.
    • References:
      Chronobiol Int. 2015;32(6):875-9. (PMID: 26102093)
      Science. 1997 May 23;276(5316):1265-8. (PMID: 9157887)
      Radiology. 2006 Aug;240(2):318-32. (PMID: 16864664)
      Sleep. 2006 Nov;29(11):1415-9. (PMID: 17162987)
      Epilepsia. 2008 Sep;49(9):1581-5. (PMID: 18410366)
      Evid Based Complement Alternat Med. 2012;2012:735078. (PMID: 22899958)
      Sleep Med Rev. 2015 Dec;24:1-12. (PMID: 25644982)
      Ann Intern Med. 2013 Feb 5;158(3):200-7. (PMID: 23295957)
      Sleep. 2005 Apr;28(4):499-521. (PMID: 16171294)
      Sleep Med Rev. 2019 Feb;43:96-105. (PMID: 30537570)
      Qual Life Res. 2014 Mar;23(2):533-7. (PMID: 23912857)
      Medicine (Baltimore). 2015 May;94(17):e809. (PMID: 25929937)
      Psychiatry Res. 1989 May;28(2):193-213. (PMID: 2748771)
      Sleep Med Rev. 2002 Apr;6(2):97-111. (PMID: 12531146)
      Curr Top Med Chem. 2011;11(8):1047-57. (PMID: 21401496)
      Sleep Med Rev. 2012 Dec;16(6):497-507. (PMID: 22440393)
      Sleep. 2008 Nov;31(11):1499-506. (PMID: 19014069)
      Psychiatry Res. 2011 Apr 30;192(1):55-9. (PMID: 21377845)
      Drug Discov Today. 2014 Sep;19(9):1410-8. (PMID: 24792719)
      J Clin Sleep Med. 2009 Jun 15;5(3):263-76. (PMID: 19960649)
    • Grant Information:
      81673733 National Natural Science Foundation of China
    • Contributed Indexing:
      Keywords: Insomnia; Jiao-tai-wan; Pattern identification; Randomized controlled trial; Study protocol; Traditional herbal medicine
    • Accession Number:
      0 (Drugs, Chinese Herbal)
      0 (jiao tai wan)
    • Publication Date:
      Date Created: 20200517 Date Completed: 20210125 Latest Revision: 20210125
    • Publication Date:
      20231215
    • Accession Number:
      PMC7227231
    • Accession Number:
      10.1186/s13063-020-04299-x
    • Accession Number:
      32414414